Vanguard Group Inc Royalty Pharma PLC Transaction History

Vanguard Group Inc

$5.37 Trillion
Q1 2025

A detailed history of Vanguard Group Inc transactions in Royalty Pharma PLC stock. As of the latest transaction made, Vanguard Group Inc holds 36,677,448 shares of RPRX stock, worth $1.22 Billion. This represents 0.02% of its overall portfolio holdings.

Number of Shares

36,677,448

Previous 37,354,009 1.81%

Holding current value

$1.22 Billion

Previous $953 Million 19.82%

% of portfolio

0.02%

Previous 0.02%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	SELL	$25.75 - $33.86 $17.4 Million - $22.9 Million	-676,561 Reduced 1.81%	36,677,448 $1.14 Billion
Q4 2024 Feb 11, 2025	SELL	$24.28 - $28.39 $5.61 Million - $6.56 Million	-231,114 Reduced 0.61%	37,354,009 $953 Million
Q3 2024 Nov 13, 2024	SELL	$25.63 - $29.27 $11.2 Million - $12.8 Million	-437,258 Reduced 1.15%	37,585,123 $1.06 Billion
Q2 2024 Aug 13, 2024	BUY	$26.26 - $29.9 $8.47 Million - $9.65 Million	322,699 Added 0.86%	38,022,381 $1 Billion
Q1 2024 May 10, 2024	SELL	$27.46 - $31.33 $8.18 Million - $9.33 Million	-297,840 Reduced 0.78%	37,699,682 $1.14 Billion
Q4 2023 Feb 14, 2024	SELL	$26.21 - $29.22 $37.7 Million - $42.1 Million	-1,439,832 Reduced 3.65%	37,997,522 $1.07 Billion
Q3 2023 Nov 14, 2023	BUY	$26.26 - $31.38 $15.5 Million - $18.5 Million	589,558 Added 1.52%	39,437,354 $1.07 Billion
Q2 2023 Aug 14, 2023	BUY	$29.6 - $36.56 $27.2 Million - $33.6 Million	917,777 Added 2.42%	38,847,796 $1.19 Billion
Q1 2023 May 15, 2023	BUY	$32.77 - $39.4 $75.4 Million - $90.7 Million	2,302,228 Added 6.46%	37,930,019 $1.37 Billion
Q4 2022 Feb 10, 2023	BUY	$39.17 - $44.04 $26.5 Million - $29.8 Million	675,981 Added 1.93%	35,627,791 $1.41 Billion
Q3 2022 Nov 14, 2022	BUY	$39.88 - $44.65 $83.7 Million - $93.7 Million	2,098,034 Added 6.39%	34,951,810 $1.4 Billion
Q2 2022 Aug 12, 2022	BUY	$37.53 - $44.22 $37.3 Million - $43.9 Million	993,155 Added 3.12%	32,853,776 $1.38 Billion
Q1 2022 May 13, 2022	BUY	$37.46 - $42.44 $83.3 Million - $94.4 Million	2,224,056 Added 7.5%	31,860,621 $1.24 Billion
Q4 2021 Feb 14, 2022	SELL	$35.17 - $42.48 $13.8 Million - $16.6 Million	-391,497 Reduced 1.3%	29,636,565 $1.18 Billion
Q3 2021 Nov 12, 2021	BUY	$36.14 - $42.24 $205 Million - $240 Million	5,685,862 Added 23.36%	30,028,062 $1.09 Billion
Q2 2021 Aug 13, 2021	BUY	$39.85 - $46.63 $970 Million - $1.14 Billion	24,342,200 New	24,342,200 $998 Million

Others Institutions Holding RPRX

# of Institutions

484

Shares Held

283M

Call Options Held

2.51M

Put Options Held

941K

View Full List

About Royalty Pharma plc

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $14.6B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

More about RPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Royalty Pharma PLC Transaction History